<DOC>
	<DOCNO>NCT02203331</DOCNO>
	<brief_summary>Purpose study test efficacy safety BAY98-7196 intravaginal ring new treatment option patient endometriosis-associated pelvic pain</brief_summary>
	<brief_title>Bay98-7196 , Dose Finding / POC Study</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Premenopausal women18 year time screen . Women endometriosis confirm laparoscopy laparotomy within last ten year less 8 week screen visit In Japan , diagnosis base imaging ( transvaginal ultrasound MRI ) also qualify inclusion . Moderate severe endometriosisassociated pelvic pain ( EAPP ) ≥5 last 28 day screen visit 1 measure numeric rating scale ( NRS ; i.e . 4week recall period ) . At randomization : Adherence study procedure screen period , least 24 diary entry ESD item 1 last 28 consecutive day randomization visit , sum available ESD item 1 ( 'worst pain ' daily NRS ) entries period least 98 ( corresponding average score ≥ 3.5 ) . Willingness use ibuprofen rescue pain medication EAPP , need accord investigator 's instruction . Use nonhormonal barrier method ( i.e . spermicidecoated condom ) contraception screen visit end study . This required adequate contraception achieve vasectomy partner Pregnancy lactation ( less three month since delivery , abortion , lactation start treatment ) Any disease condition compromise function body system could result altered absorption , excessive accumulation , impaired metabolism , alter excretion study drug Any diseases condition might interfere conduct study interpretation result . Any disease condition may worsen hormonal treatment accord assessment opinion investigator . Undiagnosed abnormal genital bleed Wish pregnancy study Regular use pain medication due underlying disease Nonresponsiveness endometriosis associate pelvic pain ( EAPP ) GnRHa surgery ( partial response exclusionary ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>